Patheon and DSM fully complementary for biologics post-merger, says DPx Exec
Patheon brings fill/finish capabilities to DSM’s biomanufacturing services, President of Biopharma at the recently merged company DPx told Biopharma-Reporter.com in an exclusive interview.